| Analysis | Metabolite Name | Measured Value | Units | Diet | Study Phase |
|---|---|---|---|---|---|
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.4689 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.4887 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.4894 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5258 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5393 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5432 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5639 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5703 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5907 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5922 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.6065 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.6140 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.6353 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.6720 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7139 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7528 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7747 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7836 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7890 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8091 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8157 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8164 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8235 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8525 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8616 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8713 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8871 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9388 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9403 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9449 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9689 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9834 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9851 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9875 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9983 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0017 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0051 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0102 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0125 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0297 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0310 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0368 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0650 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0791 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1124 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1243 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1334 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1364 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1466 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1741 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1900 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2155 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2185 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2243 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2324 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2427 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2641 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2655 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2662 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2681 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2804 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2959 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.3351 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.4123 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.4355 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.6045 | scaled imputed | Post | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.6064 | scaled imputed | Pre | 2 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.6503 | scaled imputed | Post | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.6515 | scaled imputed | Pre | 1 |
| None (Direct infusion) UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.7086 | scaled imputed | Pre | 2 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|